SCHEMBL6344156

SCHEMBL6344156

CCOC(=O)c1cnc2c(c(C)nn2-c2ccccn2)c1N

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.62
KDM4E B2RXH2 8/20 0.62
MAPT P10636 5/20 0.62
HPGD P15428 5/20 0.62
GAA P10253 1/20 0.62
HTT P42858 1/20 0.62
NPSR1 Q6W5P4 1/20 0.62
NPC1 O15118 5/20 0.61
RAB9A P51151 5/20 0.61
TP53 P04637 2/20 0.61
TSHR P16473 2/20 0.60
USP2 O75604 1/20 0.60
KMT2A Q03164 5/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
MEN1 O00255 2/20 0.59
LMNA P02545 2/20 0.59
NR3C1 P04150 1/20 0.46
PTGS2 P35354 1/20 0.46
POLB P06746 1/20 0.46
PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6351596 0.88 ALDH1A1 (0.63) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL6340224 0.87 KMT2A (0.62) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL10556383 0.76 HPGD (0.63) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL1335629 0.76 NPC1 (1.00) ALDH1A1KDM4EMAPTHPGDHTT
SCHEMBL6342455 0.75 KDM4E (0.53) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL17175815 0.75 ALDH1A1 (1.00) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL6345704 0.74 HPGD (0.64) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL4700330 0.74 HPGD (0.60) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL6290087 0.73 NR3C1 (0.61) ALDH1A1KDM4EMAPTHPGDTSHR
SCHEMBL7479238 0.73 ALDH1A1 (0.57) ALDH1A1KDM4EMAPTHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949648-B2 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-27 US disclosed
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1270572-A1 CONDENSED PYRAZOLE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof PTGS1, PTGIS, IL5 ALDH1A1 1061/4885KDM4E 1741/4885MAPT 3408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.